Retrospective Analysis of Quality of Life Changes in Patients Undergoing Parathyroidectomy for End-Stage Renal Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-05

Study Completion Date

2026-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to characterize changes in quality of life in patients who had undergone parathyroidectomy for secondary hyperparathyroidism due to end-stage renal disease, based on data extracted from an established database

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Quality of Life in Patients Undergoing Parathyroidectomy

NCT00905866

Parathyroidectomy Hyperparathyroidism

COMPLETED

Comparison of Total Parathyroidectomy With and Without Autotransplantation

NCT02536287

Secondary Hyperparathyroidism

UNKNOWN PHASE3

Pulmonary Function, Voice and Swallowing Symptoms After Parathyroidectomy

NCT04267965

Secondary Hyperparathyroidism Due to Renal Causes

COMPLETED

Quality of Life (QOL) Following Parathyroid Surgery

NCT00205452

Parathyroidectomy

COMPLETED

Near-Infrared Autofluorescence With PTH Test Strip as an SOP of Parathyroid in Thyroid Surgery

NCT05684029

Thyroid Cancer Hypoparathyroidism Optical Imaging

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Data were retrospectively collected from an established database of patients who underwent surgery for renal secondary hyperparathyroidism (SHPT). Extracted information included demographic and clinical characteristics (age, gender, education level, clinical symptoms), baseline quality of life assessed by the 36-item Short-Form Health Survey (SF-36), and completed follow-up assessments of SF-36 scores, depression, and anxiety at one, three, six months, and one year postoperatively.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Secondary Hyperparathyroidism Due to Renal Causes End Stage Renal Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Quality of life change in patients Undergoing Parathyroidectomy with end-stage renal failure

Quality of Life Progression in PatientsUndergoing Parathyroidectomy WithSecondary Hyperparathyroidism Due to End-stage Renal Failure

Quality of life progression after parathyroidectomy

Intervention Type OTHER

Study the progression of quality of life

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Quality of life progression after parathyroidectomy

Study the progression of quality of life

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Age ≥18 years； Patients who had undergone parathyroidectomy for secondary hyperparathyroidism due to end-stage renal disease.

Exclusion Criteria

Patients who underwent kidney transplantation during the study period. Patients with postoperative whole blood parathyroid hormone levels \>300 pg/mL within the first week after surgery.

Patients with missing postoperative quality of life assessment data.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No